Entity usage

Showing below up to 50 results in range #151 to #200.

151. Surveillance of individual level disease maps: Label: en
152. Disease mapping in veterinary epidemiology: a Bayesian geostatistical approach: Label: en
153. Spatio-temporal point processes, partial likelihood, foot and mouth disease: Label: en
154. Modelling geographically referenced survival data with a cure fraction: Label: en
155. Significance testing of a cluster of multivariate binary variables: comparison of the tripartite T index to three common similarity measures: Label: en
156. Checking linearity of non-parametric component in partially linear models with an application in systemic inflammatory response syndrome study: Label: en
157. Coefficients of agreement for fixed observers: Label: en
158. Estimating the variance of cancer prevalence from population-based registries: Label: en
159. Can one assess whether missing data are missing at random in medical studies?: Label: en
160. Outcome selection bias in meta-analysis: Label: en
161. Assessing the reliability of ordered categorical scales using kappa-type statistics: Label: en
162. Chance-corrected measures of reliability and validity in K K tables: Label: en
163. The role of proxy information in missing data analysis: Label: en
164. Bayesian designs with frequentist and Bayesian error rate considerations: Label: en
165. Designs in partially controlled studies: messages from a review: Label: en
166. Structural mean models for compliance analysis in randomized clinical trials and the impact of errors on measures of exposure: Label: en
167. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods: Label: en
168. Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis: Label: en
169. Uses and limitations of randomization-based efficacy estimators: Label: en
170. Multicentre trials: a US regulatory perspective: Label: en
171. Randomization-based nonparametric methods for the analysis of multicentre trials: Label: en
172. Bayesian analysis of multicentre trial outcomes: Label: en
173. The design of multicentre trials: Label: en
174. Statistical methods for HIV dynamic studies in AIDS clinical trials: Label: en
175. Revisiting proportion estimators: Label: en
176. Nonparametric methods for analysing the accuracy of diagnostic tests with multiple readers: Label: en
177. On group sequential procedures under variance heterogeneity: Label: en
178. What can modern statistics offer imaging neuroscience?: Label: en
179. Controlling the familywise error rate in functional neuroimaging: a comparative review: Label: en
180. Detecting activation in fMRI data: Label: en
181. Wavelets and statistical analysis of functional magnetic resonance images of the human brain: Label: en
182. A nonparametric changepoint model for stratifying continuous variables under order restrictions and binary outcome: Label: en
183. Fitting competing risks with an assumed copula: Label: en
184. Use of a Markov transition model to analyse longitudinal low-back pain data: Label: en
185. Review of analytical methods for prospective cohort studies using time to event data: single studies and implications for meta-analysis: Label: en
186. TSE risk assessments: a decision support tool: Label: en
187. European Union’s rapid TSE testing in adult cattle and sheep: implementation and results in 2001 and 2002: Label: en
188. Estimation of the exposure of the French population to the BSE agent: comparison of the 1980-95 consumption of beef products containing mechanically recovered meat in France and the UK, by birth cohort and gender: Label: en
189. The geographical distribution of variant Creutzfeldt-Jakob disease cases in the UK: what can we learn from it?: Label: en
190. Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis: Label: en
191. The predictability of the epidemic of variant Creutzfeldt-Jakob disease by back-calculation methods: Label: en
192. Short-term projections for variant Creutzfeldt-Jakob disease onsets: Label: en
193. Extending backcalculation to analyse BSE data: Label: en
194. Exact unconditional tests for a 2 × 2 matched-pairs design: Label: en
195. Power and sample size for ordered categorical data: Label: en
196. Saddlepoint distribution function approximations in biostatistical inference: Label: en
197. Proving non-inferiority or equivalence of two treatments with dichotomous endpoints using exact methods: Label: en
198. Methods of reducing loss of efficiency due to discreteness of distributions: Label: en
199. Dealing with discreteness: making `exact’ confidence intervals for proportions, differences of proportions, and odds ratios more exact: Label: en
200. Using inverse-weighting in cost-effectiveness analysis with censored data: Label: en